For clinical researchers shaping a pivotal study, get help choosing primary and secondary endpoints, setting out randomization and comparator options, and calculating sample-size estimates from assumptions you type in. Map safety monitoring and key analysis decisions into a protocol outline or statistical analysis plan outline. You leave with concrete planning documents to discuss with your trial statistician and regulatory team.
Phase III Trials
Plan a pivotal Phase III trial with endpoints, sample-size assumptions, and analysis choices.
Use Phase III Trials
$49.99 / month
Includes every Agent on Ai-GEN. 15,000+ Agents for one monthly price, cancel anytime.
From the creator of GPTs with 8.5M+ chats · 4.2 stars · 37K+ reviews
Start Phase III Trials — $49.99 / month
Your account is created at checkout. After payment, this Agent opens when access is ready.
Already subscribed? Sign in · Account terms
Cancel future renewals from Account & Billing → Subscriptions.
What it writes
- Phase III endpoint selection table
- Sample-size estimate with assumptions
- Protocol or analysis-plan outline
How to use it
In your first message, include the patient population, treatment and comparator, primary endpoint, expected effect, power, alpha, and any enrollment limit. Those figures make sample-size planning far more useful.
What you bring
- Target population and treatment comparison
- Endpoint and expected treatment effect
- Power, alpha, and enrollment constraints
- A defined treatment and study question
A good fit for
- Choosing endpoints for a Phase III oncology trial
- Estimating enrollment for a two-arm treatment study
- Reviewing analysis choices before a protocol meeting
Ways to start
A few requests this Agent can handle.
We’re planning a Phase III trial for a new migraine preventive against placebo. Suggest primary and secondary endpoints, and explain the trade-offs between monthly migraine days and responder rate.
Estimate sample size for a two-arm trial with 80% power, 5% two-sided alpha, 30% expected response in control, and a 10-point treatment difference. State your assumptions.
Review this proposed primary endpoint and analysis plan for a Phase III heart failure trial: time to first hospitalization or cardiovascular death, analyzed with a Cox model.
Good to know
This workspace provides text assistance.
- Medical decisions for individual patients
- Regulatory approval or ethics committee decisions
- Estimates rely on the numbers and assumptions you type.
- Cannot inspect trial files or verify current regulations.
Before you subscribe
What am I buying?
One monthly subscription that opens this Agent and every other Agent on Ai-GEN. Cancel from Account & Billing.
What happens after payment?
Checkout creates or uses your Ai-GEN account. When payment and entitlement are confirmed, the purchased Agent opens. Choose a starter task, add your inputs, and send your first request.
Can I cancel?
Yes. Manage cancellation under Account & Billing → Subscriptions. Review the status and cancellation details shown there before confirming.
Can I use the response in my work?
Use it as a draft to review and adapt. Verify calculations, facts, rights, and suitability before relying on it. Do not provide information you do not have permission to share.
Report This Agent
Tell Ai-GEN about broken behavior, poor performance, misleading capabilities, or a safety concern.